What does MEDISOLUTIONS do?

MEDISOLUTIONS is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 3 April 2008, 2 establishments.

What is the address of MEDISOLUTIONS?

The registered office of MEDISOLUTIONS is located at Rue du Développement durable(L) 24, 7900 Leuze-en-Hainaut.

Is MEDISOLUTIONS still active?

Yes. According to the CBE (31 October 2026) MEDISOLUTIONS is active, legal situation “Normale toestand”, started on 3 April 2008.

Is MEDISOLUTIONS registered on Peppol?

Yes, MEDISOLUTIONS is registered on the Peppol network with ID 0208:0896947023.

What is the enterprise number of MEDISOLUTIONS?

The enterprise number of MEDISOLUTIONS is BE0896947023.

When was MEDISOLUTIONS founded?

MEDISOLUTIONS was founded on 3 April 2008.

Who are the directors of MEDISOLUTIONS?

According to the 2025 annual accounts, the directors of MEDISOLUTIONS are: Bruno GLORIEUX.

Is MEDISOLUTIONS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 April 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did MEDISOLUTIONS make in 2025?

MEDISOLUTIONS recorded a loss after taxes of € 9,294 in financial year 2025.

What is the revenue of MEDISOLUTIONS?

As a small company, MEDISOLUTIONS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 283,707.

MEDISOLUTIONS (Private Limited) - Leuze-en-Hainaut

Dossier MEDISOLUTIONS, printed on 1 November 2026 from databakkes.be/en/0896947023/medisolutions. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDISOLUTIONS from Leuze-en-Hainaut, company number BE0896947023, closed financial year 2025 with a result of € -9,294 after tax. For that financial year MEDISOLUTIONS recorded a gross margin of € 283,707 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 203,209 to € -9,294. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.

What it is worth Healthy

€ 1.2 million

▼ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -9,294

▼ still € 203,209 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 107,743

▼ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 1.2 million.

People and assets in 2025

Wage cost

€ 76,199

▲ 6% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 9,992

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 14 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 981,106

▼ 7% vs 2024

€ 72,651 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.

Owed to suppliers

€ 68,892

▼ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 7,976

▼ 59% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,234,018 Gross margin 2022: € 1,234,018 First fiscal year in the series	€ 287,571 Gross margin 2023: € 287,571 ▼ 77% vs 2022 (€ 1,234,018) Unfavourable step	€ 427,342 Gross margin 2024: € 427,342 ▲ 49% vs 2023 (€ 287,571) Favourable step	€ 283,707 Gross margin 2025: € 283,707 ▼ 34% vs 2024 (€ 427,342) Unfavourable step	▼ 34%
Profit after taxes	€ 747,210 Profit after taxes 2022: € 747,210 First fiscal year in the series	€ 36,358 Profit after taxes 2023: € 36,358 ▼ 95% vs 2022 (€ 747,210) Unfavourable step	€ 203,209 Profit after taxes 2024: € 203,209 ▲ € 166,851 vs 2023 (€ 36,358) Favourable step	€ -9,294 Profit after taxes 2025: € -9,294 ▼ € 212,502 vs 2024 (€ 203,209) Unfavourable step	▼ € 212,502
Equity	€ 1,152,882 Equity 2022: € 1,152,882 First fiscal year in the series	€ 1,188,461 Equity 2023: € 1,188,461 ▲ 3% vs 2022 (€ 1,152,882) Favourable step	€ 1,391,046 Equity 2024: € 1,391,046 ▲ 17% vs 2023 (€ 1,188,461) Favourable step	€ 1,208,401 Equity 2025: € 1,208,401 ▼ 13% vs 2024 (€ 1,391,046) Unfavourable step	▼ 13%
Total debts	€ 488,334 Total debts 2022: € 488,334 First fiscal year in the series	€ 1,506,023 Total debts 2023: € 1,506,023 ▲ 208% vs 2022 (€ 488,334) Unfavourable step	€ 1,294,661 Total debts 2024: € 1,294,661 ▼ 14% vs 2023 (€ 1,506,023) Favourable step	€ 1,361,973 Total debts 2025: € 1,361,973 ▲ 5% vs 2024 (€ 1,294,661) Unfavourable step	▲ 5%
Cash	€ 352,726 Cash 2022: € 352,726 First fiscal year in the series	€ 200,066 Cash 2023: € 200,066 ▼ 43% vs 2022 (€ 352,726) Unfavourable step	€ 221,386 Cash 2024: € 221,386 ▲ 11% vs 2023 (€ 200,066) Favourable step	€ 107,743 Cash 2025: € 107,743 ▼ 51% vs 2024 (€ 221,386) Unfavourable step	▼ 51%
Land & buildings	€ 715,597 Land & buildings 2022: € 715,597 First fiscal year in the series	€ 1,741,314 Land & buildings 2023: € 1,741,314 ▲ 143% vs 2022 (€ 715,597) Unchanged	€ 1,474,660 Land & buildings 2024: € 1,474,660 ▼ 15% vs 2023 (€ 1,741,314) Unchanged	€ 1,434,106 Land & buildings 2025: € 1,434,106 ▼ 3% vs 2024 (€ 1,474,660) Unchanged	▼ 3%
Retained profit	€ 1,137,017 Retained profit 2022: € 1,137,017 First fiscal year in the series	€ 1,173,375 Retained profit 2023: € 1,173,375 ▲ 3% vs 2022 (€ 1,137,017) Favourable step	€ 1,376,583 Retained profit 2024: € 1,376,583 ▲ 17% vs 2023 (€ 1,173,375) Favourable step	€ 1,194,563 Retained profit 2025: € 1,194,563 ▼ 13% vs 2024 (€ 1,376,583) Unfavourable step	▼ 13%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 172,727 Dividend 2025: € 172,727 Unchanged (€ 0) Unchanged
Bank debt	€ 228,238 Bank debt 2022: € 228,238 First fiscal year in the series	€ 1,305,872 Bank debt 2023: € 1,305,872 ▲ € 1.1 million vs 2022 (€ 228,238) Unfavourable step	€ 1,052,048 Bank debt 2024: € 1,052,048 ▼ 19% vs 2023 (€ 1,305,872) Favourable step	€ 981,106 Bank debt 2025: € 981,106 ▼ 7% vs 2024 (€ 1,052,048) Favourable step	▼ 7%
Balance sheet total	€ 1,715,522 Balance sheet total 2022: € 1,715,522 First fiscal year in the series	€ 2,697,442 Balance sheet total 2023: € 2,697,442 ▲ 57% vs 2022 (€ 1,715,522) Unchanged	€ 2,753,069 Balance sheet total 2024: € 2,753,069 ▲ 2% vs 2023 (€ 2,697,442) Unchanged	€ 2,706,311 Balance sheet total 2025: € 2,706,311 ▼ 2% vs 2024 (€ 2,753,069) Unchanged	▼ 2%

Key figures of MEDISOLUTIONS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDISOLUTIONS?

What happened at MEDISOLUTIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 5, 2026 New annual accounts for financial year 2025: loss of € 9,294 (▼ € 212,502 vs 2024). Source: NBB ↗
May 15, 2008 New establishment in Beloeil. KBO
May 15, 2008 New establishment in Leuze-en-Hainaut. KBO
Apr 3, 2008 Start of the company according to the CBE. KBO

In short

From € 747,210 profit in 2022 to € 9,294 loss in 2025.

Paid € 266,376 in corporate taxes since 2022.

Best year ever: 2022, with € 747,210 profit.

Paid out € 172,727 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bruno GLORIEUX

MEDISOLUTIONS

PHARMAMED

Behind MEDISOLUTIONS is Bruno GLORIEUX. Bruno GLORIEUX is also behind PHARMAMED.

Directors

According to the 2025 annual accounts

Bruno GLORIEUX

Director

Also active at: PHARMAMED

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Développement durable(L) 24

7900 Leuze-en-Hainaut

2.170.696.880

Rue du Vert Marais (ESA) 15

7972 Beloeil

Active since 15 May 2008

2.220.449.764

Rue du Développement durable(L) 24 box 0

7900 Leuze-en-Hainaut

Active since 15 May 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0896.947.023

VAT number

BE 0896.947.023

Registered office

Rue du Développement durable(L) 24, 7900 Leuze-en-Hainaut

Names & denominations

MEDISOLUTIONS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 April 2008

Peppol

Active · Active since 15 Oct 2025

Contact

[email protected]

Activities · NACE

Overige zakelijke dienstverlening, neg

Overige detailhandel in voedingsmiddelen, neg

Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISOLUTIONS

Financials

What happened to MEDISOLUTIONS?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions